Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 53 entries
Sorted by: Best Match Show Resources per page
Bioresorbable Scaffolds and Plaque Regression: Raising the Bar in the Promised Land of Vascular Restoration Therapy.

Revista espanola de cardiologia (English ed.)

Capodanno D.
PMID: 26725972
Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):91-3. doi: 10.1016/j.rec.2015.10.006. Epub 2015 Dec 23.

No abstract available.

Deliver the drug and be resorbed: evidence from ABSORB Japan.

European heart journal

Kristensen SD, Christiansen EH, Maeng M.
PMID: 26330418
Eur Heart J. 2015 Dec 14;36(47):3343-5. doi: 10.1093/eurheartj/ehv459. Epub 2015 Sep 01.

No abstract available.

Patient with non-ST-segment elevation myocardial infarction treated by Absorb bioresorbable scaffold implantation.

Kardiologia polska

Zasada W, Rzeszutko Ł, Dziewierz A, Dudek D.
PMID: 24197595
Kardiol Pol. 2013;71(10):1091-2. doi: 10.5603/KP.2013.0269.

We present the case of a 57-year-old male patient with a diagnosis of non-ST-segment elevation myocardial infarction. Taking into consideration the clinical presentation and angiographic findings, the patient was qualified for emergent percutaneous coronary intervention with aspiration thrombectomy and...

Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease.

Kardiologia polska

Dziewierz A, Dudek D.
PMID: 30251247
Kardiol Pol. 2018;76(7):1043-1054. doi: 10.5603/KP.a2018.0130.

New-generation drug-eluting stents are recommended as the default option in all clinical conditions and lesion subsets in patients undergoing percutaneous coronary intervention (PCI). On the other hand, despite achieving very good results in the rate of restenosis, permanent delivery...

Coronary CT Angiography and Bioresorbable Vascular Scaffolds: Is There Clarity?.

JACC. Cardiovascular imaging

Cigarroa JE.
PMID: 28734925
JACC Cardiovasc Imaging. 2018 May;11(5):733-735. doi: 10.1016/j.jcmg.2017.05.006. Epub 2017 Jul 19.

No abstract available.

New and Improved: Implications of a Cardiac Support Device Composed of Biodegradable Materials.

Seminars in thoracic and cardiovascular surgery

Chung JJ, Kanade R, Atluri P.
PMID: 28683999
Semin Thorac Cardiovasc Surg. 2017;29(1):62-63. doi: 10.1053/j.semtcvs.2017.04.002. Epub 2017 Apr 04.

No abstract available.

Fully bioresorbable vascular scaffolds: lessons learned and future directions.

Nature reviews. Cardiology

Jinnouchi H, Torii S, Sakamoto A, Kolodgie FD, Virmani R, Finn AV.
PMID: 30546115
Nat Rev Cardiol. 2019 May;16(5):286-304. doi: 10.1038/s41569-018-0124-7.

Fully bioresorbable scaffolds (BRS) were designed to overcome the limitations of metallic drug-eluting stents, which permanently cage the vessel wall, thereby preventing normal coronary vasomotion, preclude bypass grafting and can provoke long-term foreign-body responses. Although multiple scaffolds have been...

What determines long-term outcomes using fully bioresorbable scaffolds - the device, the operator or the lesion?.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Yamaji K, Räber L, Windecker S.
PMID: 28119252
EuroIntervention. 2017 Feb 20;12(14):1684-1687. doi: 10.4244/EIJV12I14A277.

No abstract available.

Role of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Chamié D, Garcia-Garcia H, Costa RA, Onuma Y, Abizaid A, Serruys PW.
PMID: 27797463
Catheter Cardiovasc Interv. 2016 Nov;88:38-53. doi: 10.1002/ccd.26815.

Fully bioresorbable scaffolds (BRS) represent a novel approach for the percutaneous treatment of coronary artery stenosis, providing temporary vessel scaffolding with drug-eluting capability during the restenosis-prone phase of the vascular healing. Beyond this initial critical period, when mechanical scaffolding...

Bioresorbable scaffolds for calcified lesions: not a free lunch!.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Capodanno D.
PMID: 26999678
EuroIntervention. 2016 Mar;11(12):1334-6. doi: 10.4244/EIJV11I12A260.

No abstract available.

Vanishing act: new medical implants treat patients and dissolve when they're done.

Time

Sifferlin A.
PMID: 23326964
Time. 2012 Dec 10;180(24):18.

No abstract available.

First experience of a bioresorbable vascular scaffold implantation in left main stenosis.

International journal of cardiology

Fernández D, Brugaletta S, Martín-Yuste V, Regueiro A, de Mingo A, Santos A, Masotti M, Sabaté M.
PMID: 23351792
Int J Cardiol. 2013 Sep 30;168(2):1566-8. doi: 10.1016/j.ijcard.2012.12.061. Epub 2013 Jan 23.

No abstract available.

Showing 1 to 12 of 53 entries